Skip to main content

Share story

Science

New catalyst makes plastic upcycling 10x more efficient than platinum

New catalyst makes plastic upcycling 10x more efficient than platinum Image: Primary
Researchers at the University of Rochester and the University of North Texas have developed a tungsten carbide catalyst that breaks down polypropylene plastic waste more efficiently than platinum-based alternatives. In hydrocracking tests targeting the polymer used in water bottles and other products, the material delivered more than 10 times the efficiency of platinum catalysts. The process converts long polymer chains into smaller molecules that can be reused to produce new materials. The catalyst relies on specific metallic and acidic properties that allow bulky plastic molecules to interact without the access limits imposed by the microporous structures in platinum systems. Researchers prepared the tungsten carbide in a targeted phase using temperature-programmed carburization inside high-temperature reactors. The study, published in the Journal of the American Chemical Society, was led by Linxao Chen at the University of North Texas with support from Marc Porosoff and Siddharth Deshpande at the University of Rochester. The work forms part of broader efforts to upcycle plastic waste rather than downgrade it to lower-value forms.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from ScienceDaily and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.